reports
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
PNFP PINNACLE FINANCIAL PARTNERS INC.
FFIN FIRST FINANCIAL BANKSHARES INC
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CDXS CODEXIS
CIVB CIVISTA BANCSHARES
CZWI CITIZENS COMMUNITY BANCORP
MBIN MERCHANTS BANCORP
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
CRDF CARDIFF ONCOLOGY INC
JMSB JOHN MARSHALL BANCORP INC
MMC MARSH & MCLENNAN COMPANIES INC.
Fulcrum Therapeutics Announces Recent Business Highlights and Financia...
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025 ― Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); pociredir was generally well-tolerated with no treatment-related serious adverse events (SAEs) ― ― Observed robust and rapid pan-cellular increases in fetal hemoglobin (HbF); meaningful improvements in key markers of hemolysis and anemia; encouraging trends in vaso-occlusive crises (VOCs) ― ― On track to provide clinical data from the 20 mg dose ...
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of t...
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease ― Robust and clinically meaningful absolute mean fetal hemoglobin (HbF) induction of 8.6% from baseline at 12 weeks of treatment; 7 of 16 patients achieved absolute HbF levels greater than 20% ― ― Evidence of pan-cellular induction of HbF based on an increase in F-cells (red blood cells containing HbF) from a mean of 34% at baseline to 67% at 12 weeks of treatment ― ― Meaningful improvements in key markers of hemolysis coupled with a 0.9 g/dL mean increase i...
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of ...
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, will host a conference call and webcast on Tuesday, July 29, 2025 beginning at 8:00 a.m. ET to present topline results from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cel...
Moody's Ratings assigns B2 ratings to Clear Channel's proposed senior ...
Moody's Ratings (Moody's) assigned a B2 rating to Clear Channel Outdoor Holdings, Inc.'s (Clear Channel or the company) planned senior secured notes issuance. All other ratings are unchanged including its Caa1 Corporate Family Rating (CFR), Caa1-PD Probability of Default Rating (PDR), B2 senior secu...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an...
Appian To Announce Second Quarter 2025 Financial Results on August 7, ...
Appian To Announce Second Quarter 2025 Financial Results on August 7, 2025 MCLEAN, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced that it will release financial results for the second quarter ended June 30, 2025 before the U.S. financial markets open on Thursday, August 7, 2025. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this . Once registered, participants can join the call, usi...
PNC Financial Services Group Inc: 1 director
A director at PNC Financial Services Group Inc sold 7,665 shares at 176.000USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
- Jonathan Moreland
PLUG PLUG POWER INC.
PBF PBF ENERGY INC. CLASS A
BRKR BRUKER CORPORATION
UEIC UNIVERSAL ELECTRONICS INC.
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
BRT BRT APARTMENTS
QTRX QUANTERIX CORPORATION
RFL RAFAEL HOLDINGS CL B
BBDC BARINGS BDC INC.
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
DLHC DALEIGH HOLDINGS CORP
RNXT RENOVORX INC
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an...
- Jonathan Moreland
TDOC TELADOC HEALTH INC.
VFF VILLAGE FARMS INTERNATIONAL IN
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
VLA ARBOR METALS
DLHC DALEIGH HOLDINGS CORP
IMNM IMMUNOME
TSHA TAYSHA GENE THERAPIES
AFBI AFFINITY BANCSHARES
EVM INC.
SDHY EATON VANCE INSD CALIF MUN BD FD
PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
- Jonathan Moreland
PEB PEBBLEBROOK HOTEL TRUST
BUSE FIRST BUSEY CORPORATION
VFF VILLAGE FARMS INTERNATIONAL IN
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
BDL FLANIGAN'S ENTERPRISES INC.
RFL RAFAEL HOLDINGS CL B
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
INNV INNOVAGE HOLDING
ANTX AN2 THERAPEUTICS INC
BHRB BURKE & HERBERT BANK & TR/VA
SRBK SR BANCORP INC
JEQ THE JAPAN EQUITY FUND
LION INC.
LIONSGATE STUDIOS CORP
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
Fulcrum Therapeutics to Present at Upcoming Medical Meetings CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced upcoming presentations at the 5th Global Congress on Sickle Cell Disease and the 2025 European Hematology Association Congress. The Company’s presentations are listed below. Following congress publication, copies of the presentations will be available ...
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs G...
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference in Miami, FL on Wednesday, June 11, 2025 at 8:00 am ET. The webcast of the fireside chat will be acce...
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
LTRX LANTRONIX INC.
BRKR BRUKER CORPORATION
OFIX ORTHOFIX INTERNATIONAL N.V.
NEWT NEWTEK BUSINESS SERVICES INC.
HTLD HEARTLAND EXPRESS INC.
THS TREEHOUSE FOODS INC.
WINA WINMARK CORP.
AMBC AMBAC FINANCIAL GROUP INC.
NNBR NN
HAIN INC.
SNBR THE HAIN CELESTIAL GROUP
LILA INC.
COLD SLEEP NUMBER CORPORATION
ULBI LIBERTY LATIN AMERICA A
MIDD AMERICOLD REALTY TRUST
CCO ULTRALIFE
PRG THE MIDDLEBY CORPORATION
LESL CLEAR CHANNEL OUTDOOR HOLDINGS INC
KLXE PROG HOLDINGS
CVRX INC.
MYO LESLIES
SEAT KLX ENERGY SERVICES
DCGO CVRX
PFHC INC.
MYOMO
VIVID SEATS INC.
DOCGO INC
PROFRAC HLDG CORP
- Jonathan Moreland
MERC MERCER INTERNATIONAL INC.
BZH BEAZER HOMES USA INC.
ASB ASSOCIATED BANC-CORP
APLE APPLE HOSPITALITY REIT INC
OFIX ORTHOFIX INTERNATIONAL N.V.
THS TREEHOUSE FOODS INC.
IIFw MORGAN STANLEY INDIA INVESTMENT FUND INC.
HAIN THE HAIN CELESTIAL GROUP
CARS INC.
PMTS CARS.COM INC.
BLDR CPI CARD GROUP
CCO BUILDERS FIRSTSOURCE
RYES INC.
MTCH CLEAR CHANNEL OUTDOOR HOLDINGS INC
CIVI PATRIOT MINEFINDERS INC.
NVCT MATCH GROUP INC.
MAIA CIVITAS RESOURCES INC
VSTS_w NUVECTIS PHARMA INC
BNL MAIA BIOTECHNOLOGY INC
DMA VESTIS CORPORATION
FG BROADSTONE NET LEASE INC
DESTRA MULTI ALTERNATIVE FUND
F AND G ANNUITIES AND LIFE
INC.
- Jonathan Moreland
RGR STURM RUGER & COMPANY INC.
PEB PEBBLEBROOK HOTEL TRUST
PCAR PACCAR INC
NG. NOVAGOLD RESOURCES INC.
NBTB NBT BANCORP INC.
MTX MINERALS TECHNOLOGIES INC.
MTDR MATADOR RESOURCES COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HUN HUNTSMAN CORPORATION
HL HECLA MINING COMPANY
CHDN CHURCHILL DOWNS INCORPORATED
CFFN CAPITOL FEDERAL FINANCIAL INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
BIIB BIOGEN INC.
APLE APPLE HOSPITALITY REIT INC
OFIX ORTHOFIX INTERNATIONAL N.V.
CAT CATERPILLAR INC.
ARCB ARCBEST CORPORATION
HTLD HEARTLAND EXPRESS INC.
USAC USA COMPRESSION PARTNERS LP
NHC NATIONAL HEALTHCARE CORP.
JELD JELD-WEN HOLDING INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
OCSL OAKTREE SPECIALTY LENDING CORPORATION
SNBR SLEEP NUMBER CORPORATION
RCII RENT-A-CENTER INC
A2H9KJ NEO PERFORMANCE MATERIAL
KKR KKR & CO. INC.
REZI RESIDEO TECHNOLOGIES
TROX INC.
UTGN TRONOX HOLDINGS PLC
CCO UTG
AVTR CLEAR CHANNEL OUTDOOR HOLDINGS INC
GCI AVANTOR
DCTH INC.
ONEW GANNETT CO. INC.
DLHC DELCATH SYSTEMS
UTZ ONEWATER MARINE
OGN DALEIGH HOLDINGS CORP
NVCT UTZ BRANDS INC (A)
PRAA ORGANON & CO
VSTS_w NUVECTIS PHARMA INC
BNL PORTFOLIO RECOVERY ASSOCIATES
DMA INC.
SUNS VESTIS CORPORATION
GF BROADSTONE NET LEASE INC
FG DESTRA MULTI ALTERNATIVE FUND
EU SUNRISE REALTY TRUST
ECF THE NEW GERMANY FUND
HCWB INC.
F AND G ANNUITIES AND LIFE
INC.
WISDOMTREE EURO DEBT FUND
ELLSWORTH FUND LTD
HCW BIOLOGICS INC
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as ...
- Jonathan Moreland
RGR STURM RUGER & COMPANY INC.
NEO NEOGENOMICS INC.
MTDR MATADOR RESOURCES COMPANY
HUN HUNTSMAN CORPORATION
CHDN CHURCHILL DOWNS INCORPORATED
CFFN CAPITOL FEDERAL FINANCIAL INC.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
APLE APPLE HOSPITALITY REIT INC
OFIX ORTHOFIX INTERNATIONAL N.V.
CAT CATERPILLAR INC.
HTLD HEARTLAND EXPRESS INC.
USAC USA COMPRESSION PARTNERS LP
JELD JELD-WEN HOLDING INC.
OCSL OAKTREE SPECIALTY LENDING CORPORATION
KKR KKR & CO. INC.
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
ONEW ONEWATER MARINE
DLHC DALEIGH HOLDINGS CORP
UTZ UTZ BRANDS INC (A)
ECF ELLSWORTH FUND LTD
Fulcrum Therapeutics to Participate in Upcoming May Conferences
Fulcrum Therapeutics to Participate in Upcoming May Conferences CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following conferences: H.C. Wainwright BioConnect Investor Conference at NASDAQMay 20, 2025New York, New York RBC Capital Markets Global Healthcare ConferenceMay 21, 2025Fireside Chat at 3:35 pm ET, Participa...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.